Actively Recruiting
Influenza Vaccination After Acute Coronary Syndrome
Led by Tongji Hospital · Updated on 2026-01-13
6620
Participants Needed
1
Research Sites
173 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this clinical trial is to learn if influenza vaccination can prevent adverse cardiac events in Chinese acute coronary syndrome patients. The main questions it aims to answer are: * Whether influenza vaccination can decrease events of cardiovascular death, MI, or stroke? * Whether influenza vaccination can decrease events of all cause death, unplanned revascularization, unplanned hospitalization for heart failure or for arrhythmia, stent thrombosis? If there is a comparison group: Researchers will compare influenza vaccination and placebo to see if adverse cardiac events decrease. Participants will receive an influenza vaccination or placebo after enrollment and phone calls for follow-up at 1 month, 3 months, 6 months and 1 year after discharge.
CONDITIONS
Official Title
Influenza Vaccination After Acute Coronary Syndrome
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ACS patient aged from 18 to 80 years
- Volunteer for the study and written informed consent
You will not qualify if you...
- Participation in any drug clinical trials within 3 months
- Life-threatening complications or expected survival of 1 year or less
- Serious neurological diseases such as Alzheimer's disease, Parkinson syndrome, or progressive lower limb/deafness
- Previous cancer or tumor history, or confirmed precancerous lesions
- Refusal to comply with study requirements
- Influenza vaccination received within 1 year
- Contraindications to influenza vaccination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, China, 430030
Actively Recruiting
Research Team
Y
Yang Sun
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here